Nicholas Investment Partners, LP
Q2 2014 13F-HR Holdings
Net value change ($000)
+487,859
(40.3%)
New positions
47
Sold out positions
69
Turnover %
23.7%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2014
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| EXE | 165,745 | 3769.5% |
| WAB | 9,108 | 330.7% |
| MTDR | 7,728 | 165.0% |
| Medidata Solutions, Inc. | 7,718 | 456.4% |
| SLM | 7,592 | NEW |
| CHARTER COMMUNICATIO | 7,004 | NEW |
| ALLIED WRLD ASSUR COM HLDG A | 6,678 | 17.6% |
| CONSOL | 6,586 | 874.6% |
| MLCO | 6,514 | NEW |
| ILMN | 6,372 | 174.5% |
Top Reduces (Value $000, Stocks/ETFs)
| LVS | -9,258 | -5.6% |
| Pentair Inc | -6,007 | -100.0% |
| ACXIOM CORP | -5,644 | -100.0% |
| TCBI | -4,496 | -100.0% |
| SHORETEL INC | -4,126 | -100.0% |
| JBLU | -3,978 | -100.0% |
| BCC | -3,960 | -100.0% |
| CIEN | -3,820 | -100.0% |
| YELP | -3,576 | -100.0% |
| *SYNAGEVA BIOPHARMA CORP | -3,575 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|